HULL HANS (Chief Business Officer) received a stock award from PLIANT THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/24/2024ACC: 0001746473-24-000016
Officer· Chief Business Officer
Since Jun 2020
+94.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
94.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+31.50K
Price / share
—
Trade value
—
% of position
17.0%
1/23/2024
185.07K→216.57K
Total
Net shares
+31.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/23/2024 | A · Award | +31.50K | — | — | 17.0% | 185.07K | 216.57K |
| Total | +31.50K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
63K shares
Shares
+63K
Strike price
17.44
Held after
63K
Exercisable
—
1/23/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock63K shares | 1/23/2024 | A · Award | +63K | 17.44 | — | 63K |
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned3.82K
Common Stock
IndirectShares owned13.98K
Common Stock
IndirectShares owned13.98K
Total
31.79K indirect31.79K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 3.82K | Indirect |
| Common Stock | 13.98K | Indirect |
| Common Stock | 13.98K | Indirect |
| Total | 31.79K | 31.79K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported